Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 46, 2016 - Issue 5
514
Views
17
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Fluoxetine reduces CES1, CES2, and CYP3A4 expression through decreasing PXR and increasing DEC1 in HepG2 cells

, , , , , , , & show all
Pages 393-405 | Received 25 Jun 2015, Accepted 09 Aug 2015, Published online: 04 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jia Song, Jiaying Yu, Kai Sun, Zhixin Chen, Xiaoxiao Xing, Yumeng Yang, Chunyu Sun & Zhifei Wang. (2023) Preparation of a Highly Selective “Off-On” Rhodamine-Based Fluorescent Probe for the Specific Determination of Carboxylesterase 2 and Cell Imaging. Analytical Letters 56:15, pages 2457-2472.
Read now

Articles from other publishers (16)

Huaming Tang, Yuanli Kuang, Wan Wu, Bing Peng & Qianmei Fu. (2023) Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer. Molecular Medicine 29:1.
Crossref
Minqin Xu, Lihua Zhang, Lan Lin, Zhiyi Qiang, Wei Liu & Jian Yang. (2023) Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1. The Journal of Biomedical Research 37:6, pages 431.
Crossref
Anchal Singh, Mingze Gao, Carolyn J. Karns, Taylor P. Spidle & Michael W. Beck. (2022) Carbonate‐Based Fluorescent Chemical Tool for Uncovering Carboxylesterase 1 (CES1) Activity Variations in Live Cells. ChemBioChem.
Crossref
Joseph M. Collins, Rong Lu, Xinwen Wang, Hao-Jie Zhu & Danxin Wang. (2022) Transcriptional Regulation of Carboxylesterase 1 in Human Liver: Role of the Nuclear Receptor Subfamily 1 Group H Member 3 and Its Splice Isoforms. Drug Metabolism and Disposition 50:1, pages 43-48.
Crossref
Seiya Takemoto, Masataka Nakano, Tatsuki Fukami & Miki Nakajima. (2021) m6A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2. Biochemical Pharmacology 193, pages 114766.
Crossref
Bo Han, Hyeon‐Cheol Lee‐Okada, Momoko Ishimine, Hajime Orita, Keiko Nishikawa, Tetsuya Takagaki, Kazunori Kajino, Takehiko Yokomizo, Okio Hino & Toshiyuki Kobayashi. (2020) Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells. FEBS Open Bio 10:11, pages 2375-2387.
Crossref
Shi-Yu Liu, Ren-Yu Qu, Rong-Rong Li, Yao-Chao Yan, Yao Sun, Wen-Chao Yang & Guang-Fu Yang. (2020) An Activity-Based Fluorogenic Probe Enables Cellular and in Vivo Profiling of Carboxylesterase Isozymes. Analytical Chemistry 92:13, pages 9205-9213.
Crossref
Yue Zhou, Jian Wang, Zhuo Meng, Shuang Zhou, Jiayu Peng, Sun Chen, Qingjie Wang & Kun Sun. (2019) Pharmacology of Ivabradine and the Effect on Chronic Heart Failure. Current Topics in Medicinal Chemistry 19:21, pages 1878-1901.
Crossref
Xuan Yang, Xiao Zhang, Yamin Liu, Tao Xi & Jing Xiong. (2019) Insulin transcriptionally down-regulates carboxylesterases through pregnane X receptor in an Akt-dependent manner. Toxicology 422, pages 60-68.
Crossref
Yuanjun Shen, Zhanquan Shi & Bingfang Yan. (2019) Carboxylesterases: Pharmacological Inhibition Regulated Expression and Transcriptional Involvement of Nuclear Receptors and other Transcription Factors. Nuclear Receptor Research 6.
Crossref
Shuhua Deng, Xiaojia Ni, Dewei Shang, Zhanzhang Wang, Ming Zhang, Jinqing Hu, Xiuqing Zhu, Haoyang Lu, Yuqing Chen, Yuefeng Zhang, Huan Peng & Yuguan Wen. (2018) Effects of Alcohol on the Pharmacokinetics of Blonanserin and N-Deethylated Blonanserin in Healthy Chinese Subjects. Journal of Clinical Psychopharmacology 38:2, pages 129-133.
Crossref
Momoko Ishimine, Hyeon-Cheol Lee, Hirofumi Nakaoka, Hajime Orita, Toshiyuki Kobayashi, Konomi Mizuguchi, Mikumi Endo, Ituro Inoue, Koichi Sato & Takehiko Yokomizo. (2018) The Relationship between TP53 Gene Status and Carboxylesterase 2 Expression in Human Colorectal Cancer . Disease Markers 2018, pages 1-7.
Crossref
Niresh Hariparsad, Diane Ramsden, Jairam Palamanda, Joshua G. Dekeyser, Odette A. Fahmi, Jane R. Kenny, Heidi Einolf, Michael Mohutsky, Magalie Pardon, Y. Amy Siu, Liangfu Chen, Michael Sinz, Barry Jones, Robert Walsky, Shannon Dallas, Suresh K. Balani, George Zhang, David Buckley & Donald Tweedie. (2017) Considerations from the IQ Induction Working Group in Response to Drug-Drug Interaction Guidance from Regulatory Agencies: Focus on Downregulation, CYP2C Induction, and CYP2B6 Positive Control. Drug Metabolism and Disposition 45:10, pages 1049-1059.
Crossref
Enfang Shan, Zhu Zhu, Shuangcheng He, Dongbao Chu, Dinghao Ge, Yunran Zhan, Wei Liu, Jian Yang & Jing Xiong. (2017) Involvement of pregnane X receptor in the suppression of carboxylesterases by metformin in vivo and in vitro, mediated by the activation of AMPK and JNK signaling pathway. European Journal of Pharmaceutical Sciences 102, pages 14-23.
Crossref
Wenjing Luo, Yu Xin, Xia Zhao, Feng Zhang, Changqing Liu, Hongwei Fan, Tao Xi & Jing Xiong. (2017) Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor. British Journal of Pharmacology 174:8, pages 700-717.
Crossref
Michael Müller, Neha Agarwal & Jungtae Kim. (2016) A Cytochrome P450 3A4 Biosensor Based on Generation 4.0 PAMAM Dendrimers for the Detection of Caffeine. Biosensors 6:3, pages 44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.